Two Sigma Securities’s Sunshine Biopharma SBFM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.4K Buy
+2,348
New +$27.7K ﹤0.01% 1344
2025
Q4
Sell
-1,718
Closed -$25.6K 1942
2025
Q3
$25.6K Buy
+1,718
New +$25.5K ﹤0.01% 1090
2023
Q2
Sell
-1
Closed -$18.5K 3273
2023
Q1
$18.5K Buy
+1
New +$18.2K ﹤0.01% 2374
2022
Q4
Sell
-1
Closed -$13K 3178
2022
Q3
$13K Hold
1
﹤0.01% 2362
2022
Q2
$22K Hold
1
﹤0.01% 1945
2022
Q1
$32K Buy
+1
New +$48.7K ﹤0.01% 1926

Other funds holding SBFM

Two Sigma Securities's SBFM Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Sunshine Biopharma (SBFM) in Q1 2026: 2,348 shares worth $24.4K. The stake represents ﹤0.01% of the portfolio and ranks #1344 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in SBFM as recently as Q3 2025.

Two Sigma Securities first reported a position in SBFM in Q1 2022 and has held it in 6 quarters since. The position peaked at $32K in Q1 2022. 8 funds tracked by Wall St. Rank hold SBFM as of Q1 2026.

  • Two Sigma Securities held 2,348 shares of Sunshine Biopharma worth $24.4K as of Q1 2026.
  • Sunshine Biopharma was a new Two Sigma Securities position in Q1 2026.
  • Sunshine Biopharma made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1344 holding.
  • Two Sigma Securities first reported a position in Sunshine Biopharma in Q1 2022 and has held it in 6 quarters since.
  • Two Sigma Securities's Sunshine Biopharma position peaked at $32K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.